We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Effect and long-term outcome of hemithyroidectomy for patients with low-risk papillary thyroid carcinoma.
- Authors
Matar, Ihab; Ella, Amr Abu; Sharaky, Ahmed M.
- Abstract
Background Although the incidence of papillary thyroid carcinoma (PTC) has increased during the recent years, most of the PTCs are slow growing and considered as low-risk tumors with an excellent prognosis. This observed increase in small tumors leads to many controversies regarding the optimal surgical approach, and the extent of surgery for low-risk PTC is still the subject of debate. Recently, there is a trend toward utilizing a less-aggressive surgical approach, including the option of hemithyroidectomy for small PTCs up to 4 cm. Patients and methods This study included 60 patients with a proven diagnosis of PTC. According to the guidelines of the British Thyroid Association, the American Thyroid Association, and the American Joint Committee on Cancer, these patients would have low-risk PTCs and considered eligible for hemithyroidectomy (total lobectomy with isthmusectomy) as an initial treatment and followed up for about 5 years to detect recurrence and survival rate. Results Hemithyroidectomy was performed as an initial treatment. Completion thyroidectomy (CTx) was performed in five (8.33%) patients in the postoperative period within 1 week after the initial operation owing to identifying high-risk features in the final histopathology. During the follow-up period of the 60 patients, there was no locoregional recurrence. Recurrence was observed in three (5%) patients in the contralateral thyroid lobe within 3-4 years and was treated with a second surgery in the form of CTx. The overall rate of CTx was eight (13.33%) of 60 patients. The prognosis and the 5-year survival rate were excellent (100%). Conclusion Hemithyroidectomy in appropriately selected patients is an optimal surgical approach for treating low-risk PTC, and if recurrence occurs in the contralateral lobe, it can be treated safely by CTx, which yielded excellent curative results.
- Subjects
TUMORS; THYROID cancer; THYROID cancer treatment; THYROID cancer patients; THYROID gland surgery; HEMITHYROIDECTOMY
- Publication
Journal of Medicine in Scientific Research, 2021, Vol 4, Issue 3, p217
- ISSN
2537-091X
- Publication type
Article
- DOI
10.4103/JMISR.JMISR_97_20